Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

838 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cost and Outcome of Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA): a randomised, controlled, non-inferiority trial.
Richards DA, Ekers D, McMillan D, Taylor RS, Byford S, Warren FC, Barrett B, Farrand PA, Gilbody S, Kuyken W, O'Mahen H, Watkins ER, Wright KA, Hollon SD, Reed N, Rhodes S, Fletcher E, Finning K. Richards DA, et al. Among authors: rhodes s. Lancet. 2016 Aug 27;388(10047):871-80. doi: 10.1016/S0140-6736(16)31140-0. Epub 2016 Jul 23. Lancet. 2016. PMID: 27461440 Free PMC article. Clinical Trial.
Cost and outcome of behavioural activation versus cognitive behaviour therapy for depression (COBRA): study protocol for a randomised controlled trial.
Rhodes S, Richards DA, Ekers D, McMillan D, Byford S, Farrand PA, Gilbody S, Hollon SD, Kuyken W, Martell C, O'Mahen HA, O'Neill E, Reed N, Taylor RS, Watkins ER, Wright KA. Rhodes S, et al. Trials. 2014 Jan 21;15:29. doi: 10.1186/1745-6215-15-29. Trials. 2014. PMID: 24447460 Free PMC article. Clinical Trial.
Cost and outcome of behavioural activation versus cognitive behavioural therapy for depression (COBRA): a qualitative process evaluation.
Finning K, Richards DA, Moore L, Ekers D, McMillan D, Farrand PA, O'Mahen HA, Watkins ER, Wright KA, Fletcher E, Rhodes S, Woodhouse R, Wray F. Finning K, et al. Among authors: rhodes s. BMJ Open. 2017 Apr 13;7(4):e014161. doi: 10.1136/bmjopen-2016-014161. BMJ Open. 2017. PMID: 28408544 Free PMC article. Clinical Trial.
Cost and Outcome of BehaviouRal Activation (COBRA): a randomised controlled trial of behavioural activation versus cognitive-behavioural therapy for depression.
Richards DA, Rhodes S, Ekers D, McMillan D, Taylor RS, Byford S, Barrett B, Finning K, Ganguli P, Warren F, Farrand P, Gilbody S, Kuyken W, O'Mahen H, Watkins E, Wright K, Reed N, Fletcher E, Hollon SD, Moore L, Backhouse A, Farrow C, Garry J, Kemp D, Plummer F, Warner F, Woodhouse R. Richards DA, et al. Among authors: rhodes s. Health Technol Assess. 2017 Aug;21(46):1-366. doi: 10.3310/hta21460. Health Technol Assess. 2017. PMID: 28857042 Free PMC article. Clinical Trial.
Community Pharmacies Mood Intervention Study (CHEMIST): feasibility and external pilot randomised controlled trial protocol.
Littlewood E, Ali S, Badenhorst J, Bailey D, Bambra C, Chew-Graham C, Coleman E, Crosland S, Gascoyne S, Gilbody S, Hewitt C, Jones C, Keding A, Kitchen C, McMillan D, Pearson C, Rhodes S, Sloan C, Todd A, Watson M, Whittlesea C, Ekers D. Littlewood E, et al. Among authors: rhodes s. Pilot Feasibility Stud. 2019 May 29;5:71. doi: 10.1186/s40814-019-0457-y. eCollection 2019. Pilot Feasibility Stud. 2019. PMID: 31161045 Free PMC article.
Does a Screening Trial for Spinal Cord Stimulation in Patients with Chronic Pain of Neuropathic Origin have Clinical Utility and Cost-Effectiveness? (TRIAL-STIM Study): study protocol for a randomised controlled trial.
Eldabe S, Gulve A, Thomson S, Baranidharan G, Duarte R, Jowett S, Sandhu H, Chadwick R, Brookes M, Tariq A, Earle J, Bell J, Kansal A, Rhodes S, Taylor RS. Eldabe S, et al. Among authors: rhodes s. Trials. 2018 Nov 16;19(1):633. doi: 10.1186/s13063-018-2993-9. Trials. 2018. PMID: 30446003 Free PMC article.
Does a screening trial for spinal cord stimulation in patients with chronic pain of neuropathic origin have clinical utility and cost-effectiveness (TRIAL-STIM)? A randomised controlled trial.
Eldabe S, Duarte RV, Gulve A, Thomson S, Baranidharan G, Houten R, Jowett S, Sandhu H, Chadwick R, Brookes M, Kansal A, Earle J, Bell J, Robinson J, Walker S, Rhodes S, Taylor RS. Eldabe S, et al. Among authors: rhodes s. Pain. 2020 Dec;161(12):2820-2829. doi: 10.1097/j.pain.0000000000001977. Pain. 2020. PMID: 32618875 Free PMC article. Clinical Trial.
Correction to: Does a Screening Trial for Spinal Cord Stimulation in Patients with Chronic Pain of Neuropathic Origin have Clinical Utility and Cost-Effectiveness? (TRIAL-STIM Study): study protocol for a randomised controlled trial.
Eldabe S, Gulve A, Thomson S, Baranidharan G, Duarte R, Jowett S, Sandhu H, Chadwick R, Brookes M, Tariq A, Earle J, Bell J, Kansal A, Rhodes S, Taylor RS. Eldabe S, et al. Among authors: rhodes s. Trials. 2019 Oct 28;20(1):610. doi: 10.1186/s13063-019-3804-7. Trials. 2019. PMID: 31661015 Free PMC article.
To Trial or Not to Trial Before Spinal Cord Stimulation for Chronic Neuropathic Pain: The Patients' View From the TRIAL-STIM Randomized Controlled Trial.
Chadwick R, McNaughton R, Eldabe S, Baranidharan G, Bell J, Brookes M, Duarte RV, Earle J, Gulve A, Houten R, Jowett S, Kansal A, Rhodes S, Robinson J, Griffiths S, Taylor RS, Thomson S, Sandhu H. Chadwick R, et al. Among authors: rhodes s. Neuromodulation. 2021 Apr;24(3):459-470. doi: 10.1111/ner.13316. Epub 2020 Dec 1. Neuromodulation. 2021. PMID: 33258531 Free PMC article. Clinical Trial.
838 results